What You Should Know:
– Lindus Health, a leading innovator in clinical trial solutions, has announced the launch of its “All-in-One Women’s Health CRO” offering.
– The comprehensive suite of services and technology is specifically designed to support the unique needs of companies developing treatments and diagnostics for women’s health conditions.
Addressing the Unique Challenges of Women’s Health Research
Clinical trials for women’s health products require specialized expertise and a deep understanding of the biological factors that influence women’s health. Lindus Health’s new offering addresses these challenges by providing a tailored solution that considers the nuances of women’s health research.
All-in-One Women’s Health CRO
The “All-in-One Women’s Health CRO” offering reinforces this commitment by providing a tailored solution that addresses the unique challenges and opportunities in this critical area of healthcare. Key features include:
- End-to-End CRO Services: Lindus Health’s experienced team manages all aspects of clinical trials, from study initiation to completion.
- Advanced Recruitment Strategies: Leveraging a multi-pronged approach, including EHR screening, digital marketing, and partnerships with healthcare providers, Lindus Health accelerates patient recruitment for women’s health studies.
- Flexible eClinical Platform: Citrus™, Lindus Health’s proprietary technology, provides a comprehensive suite of tools for managing clinical trials, including CTMS, EDC, telehealth, and eConsent.
- Industry and Regulatory Expertise: Lindus Health offers expert guidance on regulatory requirements and industry best practices specific to women’s health research.
- Robust Site Services: Lindus Health’s site operations team collaborates closely with principal investigators (PIs) and research teams to ensure successful trial execution.
Market Footprint
To date, Lindus Health has enrolled over 2,500 patients in women’s health clinical trials across the US, UK, and Europe. Their comprehensive offering provides companies developing treatments and diagnostics for women’s health conditions with everything needed to manage their trials end-to-end, covering a wide range of indications such as pregnancy, postpartum depression, ovarian cancer, sexually transmitted infections (STIs), and more.
“Women have historically been underrepresented in clinical research, resulting in significant treatment disparities,” said Emma Ogburn, Vice President of Clinical Operations of Lindus Health. “Here at Lindus, it’s paramount that we help sponsors develop safe and reliable therapies for women by enrolling diverse, representative study populations while taking into account the unique aspects of their biology.”
